Redsense Medical Ab Stock EBITDA
REDS Stock | SEK 7.14 0.02 0.28% |
Redsense Medical AB fundamentals help investors to digest information that contributes to Redsense Medical's financial success or failures. It also enables traders to predict the movement of Redsense Stock. The fundamental analysis module provides a way to measure Redsense Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Redsense Medical stock.
Redsense |
Redsense Medical AB Company EBITDA Analysis
Redsense Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Redsense Medical EBITDA | (6.68 M) |
Most of Redsense Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Redsense Medical AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
According to the company disclosure, Redsense Medical AB reported earnings before interest,tax, depreciation and amortization of (6.68 Million). This is 100.76% lower than that of the Healthcare sector and 101.42% lower than that of the Medical Instruments & Supplies industry. The ebitda for all Sweden stocks is 100.17% higher than that of the company.
Redsense EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Redsense Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Redsense Medical could also be used in its relative valuation, which is a method of valuing Redsense Medical by comparing valuation metrics of similar companies.Redsense Medical is currently under evaluation in ebitda category among its peers.
Redsense Fundamentals
Price To Earning | (50.14) X | |||
EBITDA | (6.68 M) | |||
Net Income | (6.94 M) | |||
Cash And Equivalents | 3.12 M | |||
Cash Per Share | 0.28 X | |||
Total Debt | 3.04 M | |||
Debt To Equity | 75.30 % | |||
Current Ratio | 3.43 X | |||
Book Value Per Share | 0.37 X | |||
Cash Flow From Operations | (7.09 M) | |||
Earnings Per Share | (0.63) X | |||
Beta | 1.25 | |||
Market Capitalization | 123.97 M | |||
Z Score | 24.0 |
About Redsense Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Redsense Medical AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Redsense Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Redsense Medical AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Redsense Stock Analysis
When running Redsense Medical's price analysis, check to measure Redsense Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Redsense Medical is operating at the current time. Most of Redsense Medical's value examination focuses on studying past and present price action to predict the probability of Redsense Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Redsense Medical's price. Additionally, you may evaluate how the addition of Redsense Medical to your portfolios can decrease your overall portfolio volatility.